FindTrial
Sign In

Relationship between post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome and serum acylcarnitine level: A systematic review and meta-analysis

Relationship between post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome and serum acylcarnitine level: A systematic review and meta-analysis - Relationship between post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome and serum acylcarnitine level: A systematic review and meta-analysis

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000050465
Enrollment
1000
Registered
2023-03-01
Start date
2023-03-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome

Interventions

None listed

Sponsors

Saitama Medical University International Medical Center / Shonan Kamakura General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients with post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Relationship between post-COVID-19 myalgic encephalomyelitis / chronic fatigue syndrome and serum acylcarnitine level—

Countries

Japan

Contacts

Public ContactRyuhei Jinushi

Saitama Medical University International Medical Center / Shonan Kamakura General Hospital Department of Gastroenterology

gk3273@icloud.com042-984-4111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026